Showing results (771-780 of 4,513) with videos related to

Sort By:
Pageof 452
Future Oncology (London, England)|April 25, 2022
A phase III trial of alpelisib + trastuzumab ± fulvestrant versus trastuzumab + chemotherapy in HER2+ PIK3CA-mutated breast cancerJose Alejandro Pérez-Fidalgo, Carmen Criscitiello, Eva Carrasco, et al.
Future Oncology (London, England)|March 21, 2022
Real-world treatment patterns of palbociclib and blood count monitoring in patients with advanced breast cancer in JapanMasataka Sawaki, Yasuaki Muramatsu, Kanae Togo, et al.
Future Oncology (London, England)|April 5, 2022
KEYNOTE-522, IMpassion031 and GeparNUEVO: changing the paradigm of neoadjuvant immune checkpoint inhibitors in early triple-negative breast cancerAlessandro Rizzo, Antonio Cusmai, Silvana Acquafredda, et al.
Future Oncology (London, England)|April 5, 2022
Bibliometric analysis of N6-methyladenosine in cancer: landscapes, highlights and trending topicsHaotian Jiang, Yuan Li, Yinghui Liu, et al.
Future Oncology (London, England)|March 17, 2022
Real-world evidence of a successful biosimilar adoption programSophia Z Humphreys
Future Oncology (London, England)|April 13, 2022
Long-term safety and efficacy of bisphosphonate therapy in advanced lung cancer with bone metastasisZixin Wei, Bo Pan, Dexin Jia, et al.
Future Oncology (London, England)|September 29, 2018
Treatment preferences in human papillomavirus-associated oropharyngeal cancerMelina J Windon, Gypsyamber D'Souza, Carole Fakhry
Future Oncology (London, England)|October 4, 2018
Comparative immunogenicity assessment of biosimilarsThomas Schreitmüller, Bettina Barton, Artem Zharkov, et al.
Future Oncology (London, England)|September 14, 2018
Roles of miR-200 family members in lung cancer: more than tumor suppressorsCong Liu, Wei Hu, Lin-Lin Li, et al.
Future Oncology (London, England)|August 18, 2018
Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer: a randomized Phase III studyJin Li, Ruihua Xu, Shukui Qin, et al.
Pageof 452